The aspirin papers.
作者信息
Underwood M J, More R S
出版信息
BMJ. 1994 Jan 8;308(6921):71-2. doi: 10.1136/bmj.308.6921.71.
Abstract
摘要
相似文献
1
The aspirin papers.
BMJ. 1994 Jan 8;308(6921):71-2. doi: 10.1136/bmj.308.6921.71.
2
Aspirin versus clopidogrel for synthetic graft patency after peripheral arterial bypass grafting.
Platelets. 2001 Dec;12(8):503-4. doi: 10.1080/095371001317126400.
3
Aspirin as an antiplatelet drug.
N Engl J Med. 1994 May 5;330(18):1287-94. doi: 10.1056/NEJM199405053301808.
4
The role of aspirin in enhancing arterial graft patency.
J Vasc Surg. 1986 Feb;3(2):381-5.
5
Aspirin therapy in primary prevention: comment on "effect of aspirin on vascular and nonvascular outcomes".
Arch Intern Med. 2012 Feb 13;172(3):217-8. doi: 10.1001/archinternmed.2011.626. Epub 2012 Jan 9.
6
Long-term patency of regenerated neoaortic wall following the implant of a fully biodegradable polyurethane prosthesis: experimental lipid diet model in pigs.
Ann Vasc Surg. 1989 Jul;3(3):236-43. doi: 10.1016/S0890-5096(07)60031-4.
7
Dipyridamole plus aspirin and hemodialysis graft patency.
N Engl J Med. 2009 Aug 13;361(7):720-1; author reply 721.
8
Management of problems related to the occluded femoro-distal bypass.
Acta Chir Scand Suppl. 1987;538:125-31.
9
Dipyridamole plus aspirin and hemodialysis graft patency.
N Engl J Med. 2009 Aug 13;361(7):720; author reply 721. doi: 10.1056/NEJMc091312.
10
Does aspirin have a prophylactic vascular effect?
N Z Med J. 1979 Mar 14;89(631):176-7.
引用本文的文献
1
Chronic Mild Hyperhomocysteinemia Alters Inflammatory and Oxidative/Nitrative Status and Causes Protein/DNA Damage, as well as Ultrastructural Changes in Cerebral Cortex: Is Acetylsalicylic Acid Neuroprotective?
Neurotox Res. 2018 Apr;33(3):580-592. doi: 10.1007/s12640-017-9847-1. Epub 2017 Dec 14.
2
Aspirin use in middle-aged men with cardiovascular disease: are opportunities being missed?
Br J Gen Pract. 1997 Jul;47(420):417-21.
3
Clinical relevance of about-yearly changes in blood pressure and the environment.
Int J Biometeorol. 1996 Nov;39(4):161-75. doi: 10.1007/BF01221387.
4
Health promotion priorities for general practice: constructing and using "indicative prevalences".
BMJ. 1994 Apr 16;308(6935):1019-22. doi: 10.1136/bmj.308.6935.1019.
本文引用的文献
1
Who benefits from medical interventions?
BMJ. 1994 Jan 8;308(6921):72-4. doi: 10.1136/bmj.308.6921.72.
2
Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin. Overview of results of randomized trials in general, orthopedic, and urologic surgery.
N Engl J Med. 1988 May 5;318(18):1162-73. doi: 10.1056/NEJM198805053181805.
3
Antiplatelet or anticoagulant therapy after coronary artery bypass surgery. A meta-analysis of clinical trials.
Ann Intern Med. 1989 Nov 1;111(9):743-50. doi: 10.7326/0003-4819-111-9-743.
4
Fate of the patient with chronic leg ischaemia. A review article.
J Cardiovasc Surg (Torino). 1989 Jan-Feb;30(1):50-7.
5
Coronary artery bypass surgery: current practice in the United Kingdom.
Thorax. 1989 Sep;44(9):721-4. doi: 10.1136/thx.44.9.721.
6
Implications of preoperative administration of aspirin in patients undergoing coronary artery bypass grafting. Department of Veterans Affairs Cooperative Study on Antiplatelet Therapy.
J Am Coll Cardiol. 1990 Jan;15(1):15-20. doi: 10.1016/0735-1097(90)90168-o.
7
Immediate postoperative aspirin improves vein graft patency early and late after coronary artery bypass graft surgery. A placebo-controlled, randomized study.
Circulation. 1991 May;83(5):1526-33. doi: 10.1161/01.cir.83.5.1526.
8
Antiplatelet drugs in femoropopliteal vein bypasses: a multicenter trial.
J Vasc Surg. 1991 Jan;13(1):150-61; discussion 161-2.
9
Starting aspirin therapy after operation. Effects on early graft patency. Department of Veterans Affairs Cooperative Study Group.
Circulation. 1991 Aug;84(2):520-6. doi: 10.1161/01.cir.84.2.520.
10
The use of aspirin in ischemic heart disease.
N Engl J Med. 1992 Jul 16;327(3):175-81. doi: 10.1056/NEJM199207163270308.
Zotero 插件